lf 14 has been researched along with vecuronium bromide in 1 studies
| Studies (lf 14) | Trials (lf 14) | Recent Studies (post-2010) (lf 14) | Studies (vecuronium bromide) | Trials (vecuronium bromide) | Recent Studies (post-2010) (vecuronium bromide) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 2,150 | 657 | 160 |
| Protein | Taxonomy | lf 14 (IC50) | vecuronium bromide (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 3.5 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 1.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kápáti, E; Riesz, M; Szporny, L | 1 |
1 other study(ies) available for lf 14 and vecuronium bromide
| Article | Year |
|---|---|
Antagonism of non-depolarising neuromuscular blockade by aminopyridines in cats.
Topics: 4-Aminopyridine; Amifampridine; Aminopyridines; Androstane-3,17-diol; Animals; Cats; Male; Neuromuscular Nondepolarizing Agents; Pancuronium; Pipecuronium; Piperazines; Sciatic Nerve; Vecuronium Bromide | 1986 |